Furthermore, Kv1.3 displays an altered expression level in various cancers (Arcangeli et al. 2009; Comes et al. 2015; Bielanska et al. 2009), such as lymphoma (Alizadeh et al. 2000), melanoma (Artym and Petty 2002), glioma (Preussat et al. 2003), breast (Abdul et al. 2003; Jang et al. 2009), prostate (Abdul and Hoosein 2006), gastric (Lan et al. 2005) and colon cancer (Abdul and Hoosein 2002). Here, KCNA3 is linked to cancer.